News
The rapid adoption of GLP-1 receptor agonists has fundamentally altered obesity management, with these medications now ...
22hon MSN
WeightWatchers’ stock reverses gains despite weight-loss-drug subscriptions boosting revenue
WW International, the company known as WeightWatchers, brought back its full-year outlook when it reported second-quarter ...
Researchers suggest all diabetes patients on weight-loss drugs should be regularly screened and monitored for potential eye ...
Danone has launched a drinkable yogurt product under its Oikos brand in the US which looks to target users of Ozempic and ...
Danone is launching Oikos Fusion, a dairy-based drink targeting U.S. consumers using weight loss medications like Wegovy.
21h
Everyday Health on MSNGLP-1 Pill Helped People With Obesity Lose Almost 30 Pounds in New Trial
People who took the daily pill orforglipron lost 12 percent of body weight on average after 72 weeks, according to clinical trial results from Lilly.
More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the ...
Drugs such as Ozempic, Wegovy and Mounjaro (known as semaglutide and tirzepatide) have changed the way clinicians manage ...
The partnership means that Apple's fitness and wellness service will be made available to all members who enrol onto ...
Discover how GLP-1 medications and the MAHA movement are driving protein consumption and creating new opportunities for ...
Leaders at Eli Lilly believe heavy investment in the company's manufacturing footprint “sets a high standard that newcomers ...
A warning about weight loss drugs and potential eye damage. Using GLP-1 medications is associated with an increased risk for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results